Published in Neurology on May 13, 2003
Epidemiology of Alzheimer disease. Nat Rev Neurol (2011) 4.13
Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease? Nat Rev Neurosci (2010) 2.34
Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol (2014) 1.86
Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.78
Alzheimer disease. Dis Mon (2010) 1.64
Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat Rev Neurol (2013) 1.60
Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers. Nat Rev Neurol (2013) 1.43
CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma. PLoS One (2012) 1.25
Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injury. Brain (2011) 1.15
Phospholipase A2 and arachidonic acid in Alzheimer's disease. Biochim Biophys Acta (2010) 1.07
Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies. J Neural Transm (Vienna) (2005) 1.03
Amyloid-β Peptides and Tau Protein as Biomarkers in Cerebrospinal and Interstitial Fluid Following Traumatic Brain Injury: A Review of Experimental and Clinical Studies. Front Neurol (2013) 1.00
Brain injury-associated biomarkers of TGF-beta1, S100B, GFAP, NF-L, tTG, AbetaPP, and tau were concomitantly enhanced and the UPS was impaired during acute brain injury caused by Toxocara canis in mice. BMC Infect Dis (2008) 0.98
Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease. PLoS One (2013) 0.92
Dual vulnerability of tau to calpains and caspase-3 proteolysis under neurotoxic and neurodegenerative conditions. ASN Neuro (2011) 0.89
Decreased CSF transferrin in sCJD: a potential pre-mortem diagnostic test for prion disorders. PLoS One (2011) 0.87
CSF and plasma amyloid-β temporal profiles and relationships with neurological status and mortality after severe traumatic brain injury. Sci Rep (2014) 0.85
A novel, ultrasensitive assay for tau: potential for assessing traumatic brain injury in tissues and biofluids. J Neurotrauma (2014) 0.83
Head trauma and in vivo measures of amyloid and neurodegeneration in a population-based study. Neurology (2013) 0.83
Systematic review of clinical studies examining biomarkers of brain injury in athletes after sports-related concussion. J Neurotrauma (2015) 0.81
Microfluidic Valves Made From Polymerized Polyethylene Glycol Diacrylate. Sens Actuators B Chem (2014) 0.81
Emerging Roles for the Immune System in Traumatic Brain Injury. Front Immunol (2016) 0.80
The Differences between Blast-Induced and Sports-Related Brain Injuries. Front Neurol (2013) 0.79
Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury. Neurology (2004) 0.79
Addressing the needs of traumatic brain injury with clinical proteomics. Clin Proteomics (2014) 0.79
Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury. J Neurotrauma (2016) 0.79
Ameliorative Effects of Antioxidants on the Hippocampal Accumulation of Pathologic Tau in a Rat Model of Blast-Induced Traumatic Brain Injury. Oxid Med Cell Longev (2015) 0.78
Temporal MRI characterization, neurobiochemical and neurobehavioral changes in a mouse repetitive concussive head injury model. Sci Rep (2015) 0.78
Fluid biomarkers for mild traumatic brain injury and related conditions. Nat Rev Neurol (2016) 0.77
Social interaction attenuates the extent of secondary neuronal damage following closed head injury in mice. Front Behav Neurosci (2015) 0.77
Clinical review: neuromonitoring - an update. Crit Care (2013) 0.76
Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics. Front Neurol (2015) 0.76
Plasma 24S-hydroxycholesterol and other oxysterols in acute closed head injury. Brain Inj (2008) 0.75
Chronic Traumatic Encephalopathy in Athletes Involved with High-impact Sports. J Vasc Interv Neurol (2016) 0.75
Noncontact Rotational Head Injury Produces Transient Cognitive Deficits but Lasting Neuropathological Changes. J Neurotrauma (2016) 0.75
Toward precision medicine in Alzheimer's disease. Ann Transl Med (2016) 0.75
Prevalence of dementia and its correlates among participants in the National Early Dementia Detection Program during 2006-2009. Psychiatry Investig (2012) 0.75
Potential Blood-based Biomarkers for Concussion. Sports Med Arthrosc (2016) 0.75
Fluid Biomarkers of Traumatic Brain Injury and Intended Context of Use. Diagnostics (Basel) (2016) 0.75
Biomarkers of Traumatic Brain Injury: Temporal Changes in Body Fluids. eNeuro (2016) 0.75
Acute plasma tau relates to prolonged return to play after concussion. Neurology (2017) 0.75
Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases. Transl Neurodegener (2017) 0.75
Geographical analysis of medical publications in 1990. Lancet (1993) 3.98
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis. Eur J Neurol (2005) 2.67
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology (2009) 2.58
Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med (1996) 2.45
Prediction of recovery from post-traumatic vegetative state with cerebral magnetic-resonance imaging. Lancet (1998) 2.44
Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer (2005) 2.33
EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol (2009) 2.31
Attenuated corticomedullary contrast: An early cerebral computed tomography sign indicating malignant middle cerebral artery infarction. A case-control study. Stroke (1999) 2.13
Neutralising antibodies to interferon beta during the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry (2002) 2.08
Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia (2006) 1.87
Prediction of non-survival after trauma: Innsbruck Coma Scale. Lancet (1991) 1.85
Post-infectious central and peripheral nervous system diseases complicating Mycoplasma pneumoniae infection. Report of three cases and review of the literature. Eur J Neurol (2002) 1.72
A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis. Brain (2009) 1.69
The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg (2001) 1.69
Cerebral vasospasm following temporal lobe epilepsy surgery. Neurology (2012) 1.62
The persistent vegetative state after closed head injury: clinical and magnetic resonance imaging findings in 42 patients. J Neurosurg (1998) 1.60
Time course of cerebral blood flow velocity in central nervous system infections. A transcranial Doppler sonography study. Arch Neurol (1993) 1.58
Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathol Appl Neurobiol (2006) 1.57
Effects of phenylephrine on the sublingual microcirculation during cardiopulmonary bypass. Br J Anaesth (2009) 1.56
Refractory status epilepticus due to acute hepatic porphyria in a pregnant woman: induced abortion as the sole therapeutic option? Eur J Neurol (2004) 1.52
Intrathecal steroids to reduce pain after lumbar disc surgery: a double-blind, placebo-controlled prospective study. Pain (1995) 1.52
Treatment of intraventricular hemorrhage with urokinase : effects on 30-Day survival. Stroke (2000) 1.51
Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining. Antimicrob Agents Chemother (2001) 1.50
Long-term outcome of children with acute cerebellitis. Neuropediatrics (2012) 1.50
Intrathecal baclofen for intractable spasticity due to severe brain injury. Lancet (1989) 1.48
Experimental traumatic brain injury in rats stimulates the expression, production and activity of Alzheimer's disease beta-secretase (BACE-1). J Neural Transm (Vienna) (2004) 1.47
Effects of epinephrine on intestinal oxygen supply and mucosal tissue oxygen tension in pigs. Crit Care Med (2001) 1.45
Free asymmetric dimethylarginine (ADMA) is low in children and adolescents with classical phenylketonuria (PKU). J Inherit Metab Dis (2012) 1.45
[The medical-industrial complex: an ethical challenge]. Dtsch Med Wochenschr (2005) 1.40
Inotropic treatment and intestinal mucosal tissue oxygenation in a model of porcine endotoxemia. Crit Care Med (1997) 1.40
Transient restless legs syndrome after spinal anesthesia: a prospective study. Neurology (2002) 1.39
Images in clinical medicine. Waterhouse-Friderichsen syndrome. N Engl J Med (2001) 1.39
[On the tracks of humane medicine. Comments on Goethe's 250th birthday]. Dtsch Med Wochenschr (1999) 1.39
An ABA and GA modulated gene expressed in the barley embryo encodes an aldose reductase related protein. EMBO J (1991) 1.34
Apoptosis in experimental cerebral malaria: spatial profile of cleaved caspase-3 and ultrastructural alterations in different disease stages. Neuropathol Appl Neurobiol (2007) 1.28
Nosocomial ventriculitis and meningitis in neurocritical care patients. J Neurol (2008) 1.27
Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the 'Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study'. Br J Anaesth (2011) 1.26
Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic study. Intensive Care Med (2000) 1.25
A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis. Gut (2003) 1.19
Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep (2002) 1.19
Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler (2008) 1.19
Polyneuritis cranialis associated with Borrelia burgdorferi. J Neurol Neurosurg Psychiatry (1985) 1.18
Weight change and cancer risk in a cohort of more than 65,000 adults in Austria. Ann Oncol (2007) 1.17
External stabilization of long-segment tracheobronchomalacia guided by intraoperative bronchoscopy. Ann Thorac Surg (1997) 1.17
Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke (2001) 1.15
Terson's syndrome in spontaneous subarachnoid hemorrhage: a prospective study in 60 consecutive patients. J Neurosurg (1996) 1.14
Temporal profile and cell subtype distribution of activated caspase-3 following experimental traumatic brain injury. J Neurochem (2000) 1.10
Prevalence of migraine in a rural area in South Tanzania: a door-to-door survey. Cephalalgia (2004) 1.09
In vitro studies on the activity of amphotericin B and lipid-based amphotericin B formulations against Aspergillus conidia and hyphae. Mycoses (2002) 1.08
Cerebral malaria in Tanzania. Its epidemiology, clinical symptoms and neurological long term sequelae in the light of 66 cases. Trans R Soc Trop Med Hyg (1984) 1.08
Cardiac performance during vasopressin infusion in postcardiotomy shock. Intensive Care Med (2002) 1.07
Tropospheric emission spectrometer for the Earth Observing System's Aura satellite. Appl Opt (2001) 1.07
A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat. Neuroscience (1997) 1.07
Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis. Eur J Cancer (2001) 1.07
Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: implications for pathology and therapy: a review and update. J Neurotrauma (1997) 1.05
Closed reduction transarticular Kirschner wire fixation versus open reduction internal fixation in the treatment of Bennett's fracture dislocation. J Hand Surg Br (2003) 1.04
The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma - analysis of patient data in the prospective OVCAD study. Gynecol Oncol (2013) 1.03
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development. Mult Scler (2013) 1.03
Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature. Br J Cancer (2004) 1.02
Poliomyelitic-like illness in central European encephalitis. Neurology (2000) 1.02
Isolated pontine lesion in algid cerebral malaria: clinical features, management, and magnetic resonance imaging findings. Am J Trop Med Hyg (1993) 1.01
Prevalence of cervical spine injuries in patients with facial trauma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2001) 1.01
Incidence and risk of potential adverse drug interactions in the emergency room. Resuscitation (2001) 1.01
Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. J Cereb Blood Flow Metab (2000) 1.00
The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women. Ann Oncol (2007) 1.00
MRI findings in people with epilepsy and nodding syndrome in an area endemic for onchocerciasis: an observational study. Afr Health Sci (2013) 0.99
Tolerability and efficacy of N-chlorotaurine in comparison with chloramine T for the treatment of chronic leg ulcers with a purulent coating: a randomized phase II study. Br J Dermatol (2003) 0.99
Immunohistochemical study of calpain-mediated breakdown products to alpha-spectrin following controlled cortical impact injury in the rat. J Neurotrauma (1997) 0.98
Invasive Trichophyton rubrum resembling blastomycosis infection in the immunocompromised host. J Am Acad Dermatol (1998) 0.98
Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis. Neurology (2000) 0.98
"Electronic nose" detects major histocompatibility complex-dependent prerenal and postrenal odor components. Proc Natl Acad Sci U S A (2001) 0.97
Concurrent assessment of calpain and caspase-3 activation after oxygen-glucose deprivation in primary septo-hippocampal cultures. J Cereb Blood Flow Metab (2001) 0.97
EFNS-ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system. Eur J Neurol (2012) 0.97
Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting. J Neurol Neurosurg Psychiatry (2006) 0.97
HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS). Clin Exp Immunol (1998) 0.97
Early postnatal depressive mood: associations with obstetric and psychosocial factors. J Psychosom Res (1999) 0.97
CT and MR imaging in neuro-Behçet disease. J Comput Assist Tomogr (1986) 0.96
European Lyme borreliosis. Ann N Y Acad Sci (1988) 0.96
Cell index--a new parameter for the early diagnosis of ventriculostomy (external ventricular drainage)-related ventriculitis in patients with intraventricular hemorrhage? Acta Neurochir (Wien) (2004) 0.95
Prior myocardial infarction is the major risk factor associated with sudden cardiac death during downhill skiing. Int J Sports Med (2000) 0.95